Related Experiment Video

Updated: May 24, 2026

LipidUNet-Machine Learning-Based Method of Characterization and Quantification of Lipid Deposits Using iPSC-Derived Retinal Pigment Epithelium
06:16

LipidUNet-Machine Learning-Based Method of Characterization and Quantification of Lipid Deposits Using iPSC-Derived Retinal Pigment Epithelium

Published on: July 28, 2023

miRNAs as potential therapeutic targets for age-related macular degeneration

Shusheng Wang1, Kyle M Koster, Yuguang He

  • 1Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. shusheng.wang@utsouthwestern.edu

Future Medicinal Chemistry
|March 8, 2012
PubMed

Insights

MicroRNAs (miRNAs) are key regulators in age-related macular degeneration (AMD) pathogenesis. Targeting these noncoding RNAs offers promising therapeutic strategies for AMD, including choroidal neovascularization and retinal pigment epithelium atrophy.

Area of Science:

  • Ophthalmology
  • Genetics
  • Molecular Biology

Background:

  • Age-related macular degeneration (AMD) involves complex pathophysiological processes.
  • Pathological angiogenesis, oxidative stress, and inflammation are critical in AMD progression.
  • MicroRNAs (miRNAs) and other noncoding RNAs are increasingly recognized for their regulatory roles.

Purpose of the Study:

  • To review the pathological processes in AMD.
  • To identify miRNAs and noncoding RNAs regulating these processes.
  • To explore miRNA-based therapeutics for AMD.

Main Methods:

  • Literature review of AMD pathogenesis.
  • Analysis of miRNA and noncoding RNA involvement in AMD.
  • Discussion of potential therapeutic targets and delivery methods.

Main Results:

  • Specific miRNAs are implicated in choroidal neovascularization and retinal pigment epithelium atrophy.
  • These miRNAs represent promising targets for AMD therapy.
  • Various miRNA-based therapeutic approaches are under investigation.

Conclusions:

  • miRNAs play significant roles in AMD pathogenesis.
  • miRNA-based therapies hold promise for treating AMD.
  • Further research into miRNA mechanisms and delivery is warranted for AMD treatment.

More Related Videos

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.